Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
Open Access
- 8 July 2021
- journal article
- research article
- Published by Elsevier BV in The Lancet Microbe
- Vol. 2 (10), e527-e535
- https://doi.org/10.1016/s2666-5247(21)00129-4
Abstract
No abstract availableFunding Information
- CNPq
- FINEP
- MRC
- FAPESP
This publication has 26 references indexed in Scilit:
- SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivoScience, 2020
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyCell, 2020
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2Science, 2020
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020
- Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020Eurosurveillance, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task networkMemórias do Instituto Oswaldo Cruz, 2020
- Mapping the Antigenic and Genetic Evolution of Influenza VirusScience, 2004